Form D · Biotechnology

SurgiBox Inc.

Cambridge, MA · CIK 0001930227

Offering snapshot reported Sep 17, 2026 · SEC filing

Reported sold
$486K
Offering amount: $3M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 19, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 17, 2026Initial$486,000No comparison9SEC filing
Aug 8, 2024Initial$167,484No comparison22SEC filing
Aug 24, 2023Initial$749,980No comparison19SEC filing
May 26, 2022Initial$125,000No comparison5SEC filing

Offering details

Securities
Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-597931
Simple Agreement for Future Equity

Source: Form D, filed Sep 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Brown Executive
Steve Eppinger Director
Sam Goldberger Director
Julian Greene Executive
Sashidhar Jonnalagedda Executive
Macauley Kenney Executive
Kelly Laurel Director, Executive
Atif Rakin Executive
Robert Smalley Director
Mike Teodorescu Director
Debbie Teodorescu Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1035 Cambridge St. #1
Cambridge, MA, 02141
Phone: 617-394-8903